Peter Lio, MD, FAAD interviewed by Jacquelyn Dosal, MD, FAAD commentary by Angelia L. Stepien, DO with Todd Schlesinger, MD, FAAD (ed.)

JAK inhibitors have been studied to treat a wide range of dermatologic conditions. Listen as Peter Lio, MD, FAAD and Jacquelyn Dosal, MD, FAAD discuss newly approved medications and how to work as a multidisciplinary team when managing these patients.

View episode transcript